Artelo Biosciences Stock Quote ARTL - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

1.36

Bid

1.27

Ask

1.37

Volume

1,621

1.32 Day's Range 1.37

1.15 52 Week Range 2.98

Market Cap

4.39M

Previous Close

1.32

Open

1.32

Last Trade

1.35

Last Trade Time

14:28:10

Financial Volume

$ 2,185

VWAP

1.3481

Average Volume (3m)

11,930

Shares Outstanding

3,227,700

Dividend Yield

PE Ratio

-0.47

Earnings Per Share (EPS)

-2.88

Revenue

Net Profit

-9.29M

Artelo Biosciences Inc is a United States based development-stage biopharmaceutical company. It is focused on discovering, licensing, developing and commercializing treatments that control the endocannabinoid system. The company seeks to pursue technologies and programs that offer proprietary approa... Artelo Biosciences Inc is a United States based development-stage biopharmaceutical company. It is focused on discovering, licensing, developing and commercializing treatments that control the endocannabinoid system. The company seeks to pursue technologies and programs that offer proprietary approaches to cannabinoid-based therapies, including those derived from the cannabis plant and synthetic cannabinoids, as well as new chemical entities and compounds that promote the effectiveness of the endocannabinoid system. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare and orphan disease. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.artelobio.com

Headquarters

Fernley, Nevada, USA

Founded

1970

Artelo Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ARTL. The last closing price for Artelo Biosciences was $1.32. Over the last year, Artelo Biosciences shares have traded in a share price range of $ 1.15 to $ 2.98.

Artelo Biosciences currently has 3,227,700 shares outstanding. The market capitalization of Artelo Biosciences is $4.39 million. Artelo Biosciences has a price to earnings ratio (PE ratio) of -0.47.

Artelo Biosciences Presents Comparative Data from Key Preclinical Studies on ART12.11 at the 34th Annual International Cannabinoid Research Society Symposium

SOLANA BEACH, Calif., July 03, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop...

FeaturedFreedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent

Artelo Biosciences Announces Data Supporting Broad Potential Utility of its FABP Inhibitor Platform

Inhibition of FABP5 Demonstrates Activity in Cancer, Psoriasis, and Anxiety Disorders Results from Several Research Studies Presented at the Annual ICRS Symposium SOLANA BEACH, Calif., July 02...

Artelo Biosciences Presents Preclinical Data on ART26.12 in Breast Cancer-Induced Bone Pain at the 34th Annual International Cannabinoid Research Society Symposium

SOLANA BEACH, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop...

Artelo Biosciences Presents Important New Data on ART26.12 at the 57th Annual Scientific Meeting of the British Pain Society

SOLANA BEACH, Calif., June 04, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop...

Artelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer Therapy

SOLANA BEACH, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.01	0.740740740741	1.35	1.41	1.3	12945	1.33221961	CS
4	-0.02	-1.44927536232	1.38	1.44	1.1801	10103	1.32493716	CS
12	-0.2169	-13.7548354366	1.5769	1.58	1.1801	11930	1.37504671	CS
26	-0.06	-4.22535211268	1.42	1.75	1.1801	14411	1.45208621	CS
52	-0.59	-30.2564102564	1.95	2.98	1.15	79107	1.80992134	CS
156	0.21	18.2608695652	1.15	7.2	0.2599	936251	1.02905347	CS
260	-2.82	-67.4641148325	4.18	7.2	0.2599	1228103	1.41036494	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
QLGNQualigen Therapeutics Inc	$ 0.2601 (48.29%)	1.76M
CDTConduit Pharmaceuticals Inc	$ 0.8179 (27.78%)	345
STSSSharps Technology Inc	$ 0.2883 (25.35%)	632.99k
AHGAkso Health Group	$ 1.35 (16.88%)	13.32k
KOSSKoss Corporation	$ 12.41 (16.75%)	677.38k
DBVTDBV Technologies SA	$ 0.60 (-21.05%)	12k
JEWLAdamas One Corporation	$ 0.384 (-16.79%)	59.19k
ZCARZoomcar Holdings Inc	$ 0.1581 (-13.61%)	380.12k
ALBTAvalon GloboCare Corporation	$ 0.4623 (-12.28%)	340
MFImF International Ltd	$ 0.7583 (-10.79%)	3.1k
QLGNQualigen Therapeutics Inc	$ 0.2601 (48.29%)	1.76M
MAXNMaxeon Solar Technologies Ltd	$ 0.1781 (2.59%)	873.06k
FFIEFaraday Future Intelligent Electric Inc	$ 0.41595 (-1.90%)	684.88k
NVDANVIDIA Corporation	$ 127.48 (-0.62%)	680.59k
KOSSKoss Corporation	$ 12.41 (16.75%)	677.38k